THE nucleus is the defining feature of eukaryotic cells. Successful propagation of nuclei, and the genome contained within their walls, is vital for an organism's survival. Although the double lipid bilayer that forms the nuclear envelope (NE) is often viewed as a fortress, the inner and outer nuclear membranes (INM and ONM) are highly dynamic structures that undergo changes in structure and composition throughout development and differentiation, in mitosis and meiosis, and in diseased and dying cells ([@bib13]; [@bib12]; [@bib25]). Lobulated nuclei with aberrant membranes and abnormal chromosome configurations are used to grade many tumors; however, similar changes in nuclear shape and genome organization also occur during the maturation of normal cell types, most notably during hematopoiesis, suggesting a complexity at the NE that we are just beginning to understand ([@bib50]). As many of the unique properties of the NE, such as its mechanical stiffness, distinctive lipid composition, and chromosome organization, are attributed to the INM, understanding the composition, function, and regulation of the INM is a key problem in cell biology.

In all eukaryotes, the INM and ONM are joined together at many spots where nuclear pore complexes (NPCs) reside. NPCs form the first regulator of INM composition by controlling the passage of proteins and other macromolecules into and out of the nucleus. INM proteins travel through central or lateral channels of the NPC to reach the INM \[reviewed in [@bib29], [@bib59]\]. Most do not have any targeting sequence and reach the INM by diffusion; their retention at the INM occurs through binding to nuclear or NE-associated proteins such as lamins, NPCs, or chromatin ([@bib21]; [@bib67]; [@bib4]; [@bib58]; [@bib60]). A small subset of proteins is targeted to the INM by a specific sequence motif, which is recognized by the nuclear translocation machinery ([@bib31]; [@bib35]; [@bib57]; [@bib23]; [@bib54]). Additional mechanisms of INM transport have also been proposed that bypass the NPC, and rely on the budding and fusion of vesicles from the ONM to the INM ([@bib52]; [@bib39]). While many mechanistic details regarding INM transport are still poorly understood, it seems clear that the INM has a distinct composition from the ONM, which is contiguous with the ER.

In the ER, misfolded or damaged proteins are targeted for degradation by the ER-associated degradation pathway (ERAD) as part of the cell's surveillance system, to prevent the formation of nonfunctional complexes or aggregates of defective protein ([@bib69]). The conserved E3 ligases [Doa10](http://www.yeastgenome.org/locus/S000001292/overview)/MARCH6/TEB4 and [Hrd1](http://www.yeastgenome.org/locus/S000005373/overview)/SYVN1 recognize lesions in the cytosolic or luminal/membrane regions of ER proteins, respectively, resulting in ubiquitination and retro-translocation of defective proteins back into the cytoplasm for destruction by the 26S proteasome ([@bib69]). Although ERAD likely ensures that ONM proteins are functional and present in the correct stoichiometry, it is unclear if this pathway operates at the INM due to its separation from the ONM/ER by NPCs ([@bib6]). Instead, an INM-associated degradation (INMAD) pathway has been proposed to remove mistargeted proteins from the INM through ubiquitin-mediated proteolysis ([@bib19]; [@bib30]).

Three putative RING finger E3 ligases have been implicated in INMAD in yeast: [Doa10](http://www.yeastgenome.org/locus/S000001292/overview), [Asi1](http://www.yeastgenome.org/locus/S000004725/overview), and [Asi3](http://www.yeastgenome.org/locus/S000004953/overview). A broad range of [Doa10](http://www.yeastgenome.org/locus/S000001292/overview) substrates have been described in the nucleus and ER, including the *MAT*α2 transcriptional repressor, a soluble version of the kinetochore protein [Ndc10](http://www.yeastgenome.org/locus/S000003372/overview), and a mutant form of the spindle pole body (SPB) protein [Mps2](http://www.yeastgenome.org/locus/S000003043/overview) ([@bib53]; [@bib45]). [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) and [Asi3](http://www.yeastgenome.org/locus/S000004953/overview) are thought to form a multimeric E3 ligase complex together with the adapter protein [Asi2](http://www.yeastgenome.org/locus/S000005103/overview) ([@bib19]). The best-characterized substrates of this Asi complex are the transcription factors [Stp1](http://www.yeastgenome.org/locus/S000002871/overview) and [Stp2](http://www.yeastgenome.org/locus/S000001048/overview), which are ubiquitinated in the nucleus as part of the SPS ([Ssy1](https://www.yeastgenome.org/locus/S000002567)-[Ptr3](https://www.yeastgenome.org/locus/S000001925)-[Ssy5)](https://www.yeastgenome.org/locus/S000003692) sensor pathway that monitors the extracellular amino acid environment ([@bib7]; [@bib68]; [@bib42]). More recently, roles for [Doa10](http://www.yeastgenome.org/locus/S000001292/overview), [Asi1](http://www.yeastgenome.org/locus/S000004725/overview), and [Asi3](http://www.yeastgenome.org/locus/S000004953/overview) were suggested in the turnover of INM proteins, including [Erg11](http://www.yeastgenome.org/locus/S000001049/overview), [Nsg1](http://www.yeastgenome.org/locus/S000001175/overview), and [Asi2](http://www.yeastgenome.org/locus/S000005103/overview). These and other substrates were identified based on increased whole-cell protein levels in cells lacking the ligases ([@bib8]; [@bib19]; [@bib30]). Interestingly, many of the INMAD substrates identified were not INM components but proteins mistargeted to the INM, such as a mutant version of the Sec61 translocon, vacuolar transport complex subunits such as [Vtc1](http://www.yeastgenome.org/locus/S000000874/overview), and multiple plasma membrane transporters ([@bib19]; [@bib30]), leading to the idea that the primary role of INMAD is to rid the INM of non-INM proteins. The mechanisms by which INMAD distinguishes between "foreign" and "resident" membrane proteins, and whether INMAD targets damaged or misfolded INM components through a pathway similar to ERAD, remains unknown.

Examination of protein stability in rats using isotope labeling suggested that NPCs and INM proteins such as lamins are extremely long-lived, leading to the general idea that the INM is stable, with little protein turnover ([@bib47]). One important exception occurs under nutrient deprivation when nonessential sections of the entire nucleus, including the INM, are pinched off into the vacuole (the yeast lysosome) and degraded, a process known as piecemeal nuclear autophagy (PMNA) ([@bib1]; [@bib16]; [@bib46]; [@bib40]). PMNA has not yet been identified in higher eukaryotes, but autophagy of NE proteins in mammalian cells occurs ([@bib44]; [@bib17]), and is linked to both cancer and aging ([@bib38]; [@bib66]). However, a role for INMAD outside of yeast has not been reported.

We previously described a method using split-GFP that allowed us to systematically and unequivocally assay the ability of budding yeast membrane proteins to access the INM ([@bib51]). Unlike biochemical methods for studying INM composition that depend on *in silico* subtraction, or comparative analysis of nuclear and microsomal membrane samples (an ER-derived fraction formed *in vitro*), our assay is specific for the INM pool of protein, allowing for analysis of proteins that have dual functions. The assay also discriminates the INM from the ONM, using endogenously expressed proteins that serve as the sole copy in the cell and can be used in live cells. To test the contribution of INMAD to INM composition, we compared the distribution of proteins using split-GFP in wild-type cells to that of cells lacking *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)*. Comparison of INM composition in cells lacking other protein quality control components, such as the INMAD/ERAD E3 ligase [Doa10](http://www.yeastgenome.org/locus/S000001292/overview), the ERAD E3 ligase [Hrd1](http://www.yeastgenome.org/locus/S000005373/overview), the E2 ubiquitin-conjugating enzyme [Ubc7](http://www.yeastgenome.org/locus/S000004624/overview), and the vacuolar peptidase [Pep4](http://www.yeastgenome.org/locus/S000006075/overview), revealed 64 proteins whose INM levels increased in cells lacking *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)*, suggesting direct or indirect regulation by [Asi1](http://www.yeastgenome.org/locus/S000004725/overview). In *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆, we also observed an increase in the size and frequency of INM puncta containing [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)/[Tts1](https://www.pombase.org/gene/SPBC1539.04)/TMEM33, a conserved NPC-localized protein that plays a role in NPC distribution, biogenesis, and/or stability ([@bib10]; [@bib61]; [@bib70]). We provide evidence that [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) is directly ubiquitinated by [Asi1](http://www.yeastgenome.org/locus/S000004725/overview); however, ubiquitination of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) does not lead to turnover, but instead contributes to proper [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) INM distribution.

Materials and Methods {#s1}
=====================

Yeast strains and plasmids {#s2}
--------------------------

All strains are derivatives of BY (*[can1](http://www.yeastgenome.org/locus/S000000789/overview)*Δ::*STE2pr-Sp-HIS5 [lyp1](http://www.yeastgenome.org/locus/S000005212/overview)*Δ *[his3](http://www.yeastgenome.org/locus/S000005728/overview)*Δ*1 [leu2](http://www.yeastgenome.org/locus/S000000523/overview)*Δ*O [ura3](http://www.yeastgenome.org/locus/S000000747/overview)*Δ*O [met15](http://www.yeastgenome.org/locus/S000004294/overview)*Δ*O [LYS2](http://www.yeastgenome.org/locus/S000000319/overview)*). The split-GFP library was made by first integrating the pRS315-*NOP1pr-GFP~11~-mCherry-[PUS1](http://www.yeastgenome.org/locus/S000006133/overview)* (pSJ1321) reporter into a *MAT*α derivative to create SLJ7859 (*MAT*α *[can1](http://www.yeastgenome.org/locus/S000000789/overview)*Δ::*STE2pr-Sp-HIS5 [lyp1](http://www.yeastgenome.org/locus/S000005212/overview)*Δ *[his3](http://www.yeastgenome.org/locus/S000005728/overview)*Δ*1 [leu2](http://www.yeastgenome.org/locus/S000000523/overview)*Δ*O [ura3](http://www.yeastgenome.org/locus/S000000747/overview)*Δ*O [met15](http://www.yeastgenome.org/locus/S000004294/overview)*Δ*O [LYS2](http://www.yeastgenome.org/locus/S000000319/overview)* p*[LEU2](http://www.yeastgenome.org/locus/S000000523/overview)*-*NOP1pr-GFP~11~-mCherry-[PUS1](http://www.yeastgenome.org/locus/S000006133/overview)*).

Construction of a C-terminally tagged library of membrane proteins with *GFP~1--10~-URA3MX* (pSJ1256) by PCR was previously described ([@bib51]). Briefly, genes associated with the gene ontology annotation of integral component of membrane or transmembrane were compiled using the Saccharomyces Genome Database (SGD), and TMHMM v2 software ([@bib32]) was used to predict additional genes containing hydrophobic stretches of \> 16 amino acids using a version of the genome downloaded on 6/10/2012. These genes were then tagged by PCR, resulting in a library of 1010 strains. Although 169 of the clones appeared to be soluble, these were kept in the library because it was unknown if their membrane association/integration was regulated, was disrupted by C-terminal tagging, or if they lacked a *bona fide* membrane domain ([@bib51]). The library was crossed to deletion mutants taken from the yeast deletion collection (*MAT***a** *yfg*∆::*KANMX [LYP1](http://www.yeastgenome.org/locus/S000005212/overview)[CAN1](http://www.yeastgenome.org/locus/S000000789/overview)[his3](http://www.yeastgenome.org/locus/S000005728/overview)[ura3](http://www.yeastgenome.org/locus/S000000747/overview)[leu2](http://www.yeastgenome.org/locus/S000000523/overview)*) using the Singer RoToR robot as previously described ([@bib56]). Following diploid selection on synthetic defined media lacking uracil with monosodium glutamate and G418 (SD/MSG-Ura+G418), cells were sporulated for 3--4 weeks, then haploids containing the deletion and the tags were selected twice on SD/MSG-Ura-Leu-His-Lys-Arg+thialysine+canavanine+G418. All plates were incubated at 23°. We did not recover certain combinations of deletion mutants/tagged genes/selection markers due to linkage and slow growth of certain strains. Therefore, mutant libraries contained fewer genes than the original library. A complete list of genes screened can be found in Supplemental Material, Tables S1 and S2.

For colocalization experiments, we used the pRS315-*NOP1pr-GFP11*-*[PUS1](http://www.yeastgenome.org/locus/S000006133/overview)* (pSJ1679) reporter so that genes could be C-terminally tagged with mCherry using pFA6-*mCherry-KANMX* by PCR. Strains used for each experiment are listed in Table S4, with the exception of strains taken directly from our split-GFP libraries.

INM mutant screen {#s3}
-----------------

Cells were grown overnight at 23° in SC-Leu in a 96-well plate format, using deep-well dishes (Thermo-Scientific). Imaging plates (Ibidi) were pretreated with 100 μl of polylysine (Sigma \[Sigma Chemical\], St. Louis, MO) for 1 hr, and then rinsed twice with water and allowed to dry before use. Cells were plated using 100 μl of culture. Each plate was imaged on a Nikon (Garden City, NY) Eclipse TI equipped with a Yokogawa CSU W1 spinning disk head and Andor EMCCD using a Nikon Apo TIRF 100× 1.49NA Oil objective. mCherry was imaged using a 561-nm laser at 100% power and ET605/70m emission filter, with an exposure time of 100 msec. GFP was imaged using a 488-nm laser at 100% power and ET535/30m emission filter, with an exposure time of 200 msec. Four points were automatically selected for each well. An automation script moved to positions, found focus using Nikon perfect focus system (PFS), and imaged each channel with a z-stack of 13 slices and spacing of 0.5 µm. Image processing was performed in ImageJ using custom macros and plugins.

In brief, images were background-subtracted and sum-projected in z, and for each cell a mask of the nucleus was generated based on the mCherry channel, as well as a ring mask surrounding the nucleus to measure the cytoplasmic signal. mCherry and GFP intensity were measured in the nuclear and ring masks for each cell. Cells with a high cytoplasmic signal were discarded as dead cells. For each live cell, the nuclear GFP/mCherry intensity ratio was calculated; from these data the average ratio per sample was calculated, and for each protein the mutant/wild-type ratio was calculated from these averages (given in Table S1). Proteins were counted as hits if the mutant/wild-type ratio was \> 1.4.

Wild-type and *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ images were manually inspected for signal in both the 561- and 488-nm channels. If no signal was present upon visual inspection, the sample was categorized as a false positive and was removed from subsequent analysis with all mutants. These genes are listed in Table S2; most correspond to negatives or nonabundant INM hits in wild-type cells ([@bib51]). If signal was detected in the nucleus rather than the INM, the sample was categorized as nuclear. This could occur because the protein is not a *bona fide* transmembrane protein, because its binding partner at the INM is absent, or because C-terminal tagging interfered with membrane association ([@bib51]).

Confocal imaging {#s4}
----------------

Cells were grown overnight in SC-Leu in 2-ml cultures, and then harvested for imaging and immobilized on polylysine slides (Polysciences, Warrington, PA). Imaging was conducted on a Zeiss (\[Carl Zeiss\], Thornwood, NY) LSM780. All images were taken using a 40× water objective, fluorophores were excited using a 488- and 561-nm Argon laser line, GFP emission was collected through a BP 505--540-nm filter, and mCherry was collected through a LP 580-nm filter, with the pinhole set to 1 airy units. Images taken for puncta quantification, puncta measurement, and colocalization experiments had a zoom of 6, and z-stack of 10--12 slices. Puncta widths were measured from manually drawn line profiles over puncta averaged over a thickness of eight pixels. Profiles were then aligned to their peak maxima and averaged to determine average peak profiles. They were then fitted to Gaussian functions using nonlinear least squares to determine their width. Error bars were determined from Monte Carlo analysis with 100 random simulations, as previously described ([@bib5]).

Ubiquitination of Pom33 {#s5}
-----------------------

Liquid nitrogen ground lysates were prepared as previously described in [@bib28], [@bib9], and [@bib20]. Cells of the indicated genotypes were grown overnight, then diluted into 1-liter cultures in the morning to an OD~600~ of ∼0.2. Cells were allowed to grow until midlog phase and then harvested. Extraction buffer was adjusted for each sample so that an OD~600~ of 1.0 would have 5 ml of extraction buffer added. Cells were then dropped into liquid nitrogen to make yeast dots and frozen at −80°. Yeast powder was made by grinding the frozen yeast dots using a Retsch ball mill 4 × 3 min, 30 Hz. Powder was then collected and weighed out to equal amounts for each sample (∼5 mg). Ground cell powder was thawed on ice, then resuspended in 9 ml of extraction buffer (20 mM HEPES-NaOH, pH 7.5; 300 mM NaCl; 1 mM EDTA; 5 mM EGTA; 50 mM NaF; 50 mM β-glycerophosphate; 0.5% TritonX-100; 1 mM DTT; 1 mM PMSF; and 1 mg/ml each pepstatin A, aprotinin, and leupeptin). Next, samples were homogenized with a Polytron 10/35 for 30 sec, lysates were centrifuged at 3000 × *g* for 10 min at 4°, and the resulting supernatant was used for immunoprecipitations. In addition, 100 µl of each lysate with 200 µl of 2× SDS (sodium dodecyl sulfate) sample buffer was saved for western blot analysis. Lysates were added to protein G Sepharose beads (GE Healthcare) that had been previously incubated with P4D1 anti-ubiquitin antibody (1:500 µl; Cell Signaling Technology) and rotated for ∼3 hr at 4°. Beads were washed 5× with extraction buffer before western blot analysis, and then 200 µl of SDS sample buffer was added before western blot analysis. Proteins were detected using (1:1000) anti-GFP antibody (Cell Signaling Technology).

To compare the amount of ubiquitinated [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) between samples, we first determined the relative abundance of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ in each whole-cell lysate using histone H4 as a reference \[1:10,000 anti-histone H4 antibody (Abcam)\]. The amount of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ protein recovered in each ubiquitin pull-down was then adjusted accordingly. Western blots were quantitated as previously described ([@bib28]; [@bib9]; [@bib20]); because [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ ran as a doublet, the entire region containing both bands was included in the analysis.

Cycloheximide chase experiments {#s6}
-------------------------------

Cells were grown overnight and diluted back the next morning, then allowed to recover to midlog phase before the addition of cycloheximide (125 µg/ml). Samples were removed at given time points and quick-frozen in liquid nitrogen for further analysis by western blotting, using (1:1000) anti-MYC antibody (Cell Signaling Technology) or (1:1000) anti-GFP antibody (Cell Signaling Technology), (1:10,000) anti-histone H4 antibody (Abcam), and (1:1000) anti-Clb2 (Santa Cruz Biotechnology). For the *[cim3-1](https://www.yeastgenome.org/locus/S000003016)* experiments, cells were shifted to the nonpermissive temperature of 37° for 45 min before the addition of cycloheximide.

Data availability {#s7}
-----------------

All strains are listed in Table S4 and are available upon request. Split-GFP and PCR tagging plasmids have been deposited at AddGene. Custom macros and plugins used for image processing and quantitation with Image J are available at <http://research.stowers.org/imagejplugins/index.html>. Original data underlying this manuscript can be downloaded from the Stowers Original Data Repository at <http://www.stowers.org/pubs/LIBPB-1363_2018>. Supplemental material available at Figshare: <https://doi.org/10.25386/genetics.7646975>.

Results {#s8}
=======

Screen for INM changes in protein quality control mutants {#s9}
---------------------------------------------------------

To detect if proteins are able to access the INM, we expressed a soluble nuclear protein at high levels fused to half of split-GFP (GFP~11~-mCherry-[Pus1](http://www.yeastgenome.org/locus/S000006133/overview)); this can reconstitute a working GFP when a protein fused to GFP~1--10~ localizes to the same compartment ([Figure 1A](#fig1){ref-type="fig"}). Previously, we showed that 312 of 1010 C-terminally tagged membrane or predicted membrane proteins in yeast have access to the INM using the split-GFP assay ([@bib51]). Of the 1010 C-terminally tagged genes in the library, 169 localized throughout the nucleus (nuclear) because they encoded a soluble protein or because C-terminal tagging disrupted membrane association, while 529 did not exhibit any signal ([Figure 1E](#fig1){ref-type="fig"}).

![Mutation of *ASI1* alters split-GFP signal of a subset of INM proteins. (A) Schematic showing split-GFP and its use to detect proteins that can access the INM (denoted with asterisk). (B) Plot of the split-GFP mutant/WT ratios for each gene reported from 96-well plate imaging analysis of membrane proteins in *asi1*∆, *ubc7*∆, *doa10*∆, *hrd1*∆, and *pep4*∆. Dashed line represents the 1.4 cutoff. (C) Representative images of proteins that were categorized previously as negative or positive (INM or soluble) that remained unchanged in *asi1*∆, based on an *asi1*∆/WT ratio of 1.39 or lower. (D) Signal of proteins that changed in *asi1*∆ largely fell into three categories: proteins that were previously negative, and proteins that were positive (INM or soluble) that increased in *asi1*∆. The number of proteins assigned to each category for (B and C) is on the right, based on an *asi1*∆/WT ratio of 1.4 or higher. (E) The starting library contained 1010 genes, including 312 that localized to the INM in WT cells, 169 that gave a soluble nuclear signal, and 529 that were negative. Of the 725 genes analyzed in the *asi1*∆ mutant, 74 were hits using the 1.4 ratio cutoff. The fraction (number) of *asi1*∆ hits that localized to the INM, nucleus, or were negative in WT cells is shown. Similarly, a summary of starting library localization based on WT results is also plotted for the other mutants, with the total number of genes analyzed listed at the top and the number of hits in each category shown. Bar, 2 μm. INM, inner nuclear membrane; ONM, outer nuclear membrane; WT, wild-type.](1269f1){#fig1}

To determine how the INM proteome is altered by the removal of quality control systems, we examined INM localization of the same library in cells lacking *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)* (INMAD), *[DOA10](http://www.yeastgenome.org/locus/S000001292/overview)* (INMAD/ERAD), *[HRD1](http://www.yeastgenome.org/locus/S000005373/overview)* (ERAD), *[UBC7](http://www.yeastgenome.org/locus/S000004624/overview)* (INMAD/ERAD and other pathways), and *[PEP4](http://www.yeastgenome.org/locus/S000006075/overview)* (vacuole). Wild-type and mutant strains were screened using a high-throughput 96-well plate imaging format, and images were quantitatively assessed for INM signal using an automated image analysis pipeline. Although it is unlikely that the amount of nuclear reporter is limiting as it is present in high copy, levels of GFP~11~-mCherry-[Pus1](http://www.yeastgenome.org/locus/S000006133/overview) could affect the amount of 488 fluorescence visualized, so we first normalized to mCherry levels on a cell-by-cell basis. Next, we averaged the split-GFP signal for each protein/mutant combination to eliminate possible cell cycle/cell growth artifacts, and then used this value to determine the final intensity ratio of wild-type and each mutant (Table S1).

Manual inspection of images in cells lacking *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)* compared to wild-type showed that only 725 of the 833 genes tested in the mutant could be reliably scored. False positives (Table S2) were removed from analysis of all mutants tested, due to a lack of signal in wild-type and *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆, or suspected low expression levels or higher amounts of autofluorescence. The mating pheromone receptor [Ste2](http://www.yeastgenome.org/locus/S000001868/overview) was also a false positive due to the *MAT***a** mating type of strains used for mutant analysis *vs.* the *MAT*α strain we used for wild-type (Figure S1). If we examined [Ste2](http://www.yeastgenome.org/locus/S000001868/overview)-GFP~1--10~ in a wild-type *MAT***a** strain, it localized to the INM like the mutants (Figure S1). No other INM components were obviously affected by mating type.

Our analysis showed that the distribution of most proteins was unaffected in the deletions, resulting in ratio values ∼1 ([Figure 1, B and C](#fig1){ref-type="fig"}). Using a cutoff of 1.4, which is slightly \< 1 SD above the mean for most samples, we found that 10--26% of proteins showed an increase above wild-type. This included increased levels for 74/725 proteins in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆, 177/672 in *[ubc7](http://www.yeastgenome.org/locus/S000004624/overview)*∆, 97/705 in *[doa10](http://www.yeastgenome.org/locus/S000001292/overview)*∆, 105/707 in *[hrd1](http://www.yeastgenome.org/locus/S000005373/overview)*∆, and 141/686 in *[pep4](http://www.yeastgenome.org/locus/S000006075/overview)*∆ ([Figure 1E](#fig1){ref-type="fig"}). These hits could be further subdivided into three categories based on their localization in wild-type. For example, 21 proteins present at the INM in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ did not localize to the INM in wild-type, 10 were soluble and nucleoplasmic, and 43 were at the INM but increased in cells lacking *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)* ([Figure 1, D and E](#fig1){ref-type="fig"}). Overrepresentation of INM components in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ (58%) compared to other mutants (34%) points to the idea that [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) affects native INM components. Consistent with this possibility, the well-characterized INM components [Pom33](http://www.yeastgenome.org/locus/S000003946/overview), [Per33](http://www.yeastgenome.org/locus/S000004054/overview), [Asi2](http://www.yeastgenome.org/locus/S000005103/overview), and [Heh2](http://www.yeastgenome.org/locus/S000002866/overview) were identified as hits in our *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ screen (Tables S1 and S3), as discussed below.

In each mutant analyzed, we identified increased INM access of a unique combination of split-GFPs (Table S3). Cells lacking the E2 ubiquitin-conjugating enzyme [Ubc7](http://www.yeastgenome.org/locus/S000004624/overview) partially overlapped with the E3 ligases, consistent with the idea that [Ubc7](http://www.yeastgenome.org/locus/S000004624/overview) plays a role in both ERAD and INMAD. The partial overlap between *[doa10](http://www.yeastgenome.org/locus/S000001292/overview)*∆ and *[hrd1](http://www.yeastgenome.org/locus/S000005373/overview)*∆ or *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ mutants (Figure S2A) is similar to previous reports suggesting that [Doa10](http://www.yeastgenome.org/locus/S000001292/overview) also plays a role in both pathways ([@bib19]; [@bib30]). We tested 12 of 20 previously reported [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) substrates from a whole-cell assay based on the tandem timer ([@bib30]). From this, we confirmed increased INM localization in 8 of the 12, including the vacuolar transferase complex subunit [Vtc1](http://www.yeastgenome.org/locus/S000000874/overview) that is thought to be mistargeted to the INM due to protein tagging ([@bib30]), the Rab GTPase-interacting protein [Yip4](http://www.yeastgenome.org/locus/S000003166/overview), the plasma membrane transporter [Zrt2](http://www.yeastgenome.org/locus/S000004120/overview), inositolphosphotransferase [Ipt1](http://www.yeastgenome.org/locus/S000002479/overview), and [Irc23](http://www.yeastgenome.org/locus/S000005570/overview), a protein of unknown function that is linked to DNA damage (Figure S2B). We also saw similar effects for *[ubc7](http://www.yeastgenome.org/locus/S000004624/overview)*∆. Perhaps unsurprisingly, our screen for INM proteins affected by *[doa10](http://www.yeastgenome.org/locus/S000001292/overview)*∆ or *[hrd1](http://www.yeastgenome.org/locus/S000005373/overview)*∆ showed limited overlap with [Doa10](http://www.yeastgenome.org/locus/S000001292/overview) or [Hrd1](http://www.yeastgenome.org/locus/S000005373/overview) substrates found by [@bib19] and [@bib30], who used whole-cell based methods that would detect ER substrates. It is unknown if protein levels and/or INM localization is a direct or indirect consequence of the [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) deletion; therefore, we performed more detailed analysis on a subset of mutants and proteins.

Pom33 distribution is altered in cells lacking ASI1 {#s10}
---------------------------------------------------

In addition to a change in protein levels, one of the most interesting phenotypes that we observed in INM quality control mutants was the appearance of puncta: increased levels of INM protein at one or more NE locations in the presence of background fluorescence throughout the membrane. A striking example is shown in [Figure 2A](#fig2){ref-type="fig"} for the paralogs, [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) and [Per33](http://www.yeastgenome.org/locus/S000004054/overview), in cells lacking *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)*. The INM component [Heh2](http://www.yeastgenome.org/locus/S000002866/overview) and the NPC pore membrane protein [Pom34](http://www.yeastgenome.org/locus/S000004008/overview) did not form puncta in any mutant analyzed ([Figure 2A](#fig2){ref-type="fig"} and Figure S3), suggesting that puncta formation is specific to [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) and [Per33](http://www.yeastgenome.org/locus/S000004054/overview), and not a general feature of INM or NPC pore components in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆. [Pom34](http://www.yeastgenome.org/locus/S000004008/overview) was identified as a potential Ubc7-dependent, Hrd1- and Doa10-independent target in a previous proteomic screen for [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) targets ([@bib19]), and in our analysis it did exhibit a slight ratio increase for *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ (1.27) and *[ubc7](http://www.yeastgenome.org/locus/S000004624/overview)*∆ (1.35). Unlike the puncta formation we previously observed for a number of proteins using split-GFP ([@bib51]), the puncta formed by [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) were specifically linked to INM quality control pathways, forming in mutant cells lacking *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)*, *[ASI2](http://www.yeastgenome.org/locus/S000005103/overview)*, *[UBC7](http://www.yeastgenome.org/locus/S000004624/overview)*, and to a lesser extent *[ASI3](http://www.yeastgenome.org/locus/S000004953/overview)* ([Figure 2, A and C](#fig2){ref-type="fig"} and Figure S3). [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) levels at the INM were reduced in both *[doa10](http://www.yeastgenome.org/locus/S000001292/overview)*∆ and *[hrd1](http://www.yeastgenome.org/locus/S000005373/overview)*∆ (Figure S3 and Table S1). [Per33](http://www.yeastgenome.org/locus/S000004054/overview) puncta also formed in ERAD mutants (Figure S3) and were not studied further.

![Pom33 INM distribution is altered in Asi complex mutants. (A) Comparison of reconstituted GFP signal for Pom33-GFP~1--10~, Per33-GFP~1--10~, Heh2-GFP~1--10~, and Pom34-GFP~1--10~ with GFP~11~-mCherry-Pus1 in wt cells and cells lacking *ASI1*, *ASI2*, or *ASI3*. (B) Quantitation of total protein levels for Pom33-GFP~1--10~ in wt, *asi1*∆, *asi2*∆, and *asi3*∆ cells. An untagged strain was also used (−). Pom33-GFP~1--10~ levels were first normalized to histone H4 signal and the mutant levels each compared to wt, which was set at 1; ratios set at bottom are an average from four separate blots. (C) The frequency of Pom33-GFP~1--10~ puncta increases in mutants of *ASI1* and *ASI2*. Total cells counted (*n*) for each sample depicted on graph. (D) The average puncta width measured by FWHM of fluorescence intensity at the puncta. Total puncta measured (*n*) depicted on graph. In (C and D), *P*-values were determined by Students *t*-test. Error bars equal SEM. (E) Localization of Pom33-GFP in wt, *asi1*∆, *asi2*∆, and *asi3*∆ cells. Percentage of cells with puncta reported in the lower right corner. *n* \> 125 cells. Bar, 2 μm. FWHM, full width at half maximum; INM, inner nuclear membrane; wt, wild-type.](1269f2){#fig2}

Quantitation of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) at the INM showed that there was little change in intensity or total [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) levels in wild-type and mutants ([Figure 2, A and B](#fig2){ref-type="fig"}), but that the frequency of puncta more than doubled in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ and *[asi2](http://www.yeastgenome.org/locus/S000005103/overview)*∆ cells ([Figure 2C](#fig2){ref-type="fig"}). Importantly, the formation of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) puncta was not simply due to split-GFP as they were also observed in cells expressing [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ and *[asi2](http://www.yeastgenome.org/locus/S000005103/overview)*∆ ([Figure 2E](#fig2){ref-type="fig"}). Previous work showed that [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP not only localizes to the INM but also to the ONM/ER ([@bib10]), which can be seen in images with full-length GFP ([Figure 2E](#fig2){ref-type="fig"}). As the ONM/ER pool of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) is unlikely to be affected by deletion of *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)* or *[ASI2](http://www.yeastgenome.org/locus/S000005103/overview)*, puncta are not as pronounced as in [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~/GFP~11~-mCherry-[Pus1](http://www.yeastgenome.org/locus/S000006133/overview) cells where the nuclear pool is exclusively detected ([Figure 2A](#fig2){ref-type="fig"}). The effects of *[asi3](http://www.yeastgenome.org/locus/S000004953/overview)*∆ on [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) puncta formation were also not as pronounced, similar to previous studies showing that the *[asi3](http://www.yeastgenome.org/locus/S000004953/overview)*∆ mutant had a milder effect on INMAD compared to *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ ([@bib30]). The puncta formed in the mutants, particularly in [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~/GFP~11~-mCherry-[Pus1](http://www.yeastgenome.org/locus/S000006133/overview) cells, are considerably larger than in wild-type cells ([Figure 2D](#fig2){ref-type="fig"}), suggesting that [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) and [Asi2](http://www.yeastgenome.org/locus/S000005103/overview) affect [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) distribution at the INM.

Ubiquitination of Pom33 regulates INM distribution but not degradation {#s11}
----------------------------------------------------------------------

To understand how [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) and [Asi2](http://www.yeastgenome.org/locus/S000005103/overview) affect [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) distribution at the INM, we considered the possibility that [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) is a target of the ubiquitin ligase activity of [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) and is ubiquitinated *in vivo*. Ubiquitinated proteins were immunoprecipitated from lysates containing [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) and [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~, with and without *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)*, with an anti-ubiquitin antibody. These cells also contained the GFP~11~-mCherry-[Pus1](http://www.yeastgenome.org/locus/S000006133/overview) reporter. As a positive control, we immunoprecipitated an N-terminal fusion of ubiquitin to [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ (Ub-[Pom33](http://www.yeastgenome.org/locus/S000003946/overview)). [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) is unlikely to be ubiquitinated at the N-terminus, but this control construct is able to serve as a functional version of *[POM33](http://www.yeastgenome.org/locus/S000003946/overview)*, rescuing the NPC clustering phenotype caused by *[pom33](http://www.yeastgenome.org/locus/S000003946/overview)*∆ to the same extent as [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ (Figure S4). We analyzed these immunoprecipitates by western blotting with an anti-GFP antibody. Although a ladder of bands was not present to indicate polyubiquitination, we enriched for [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ from wild-type but not *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ cells in these experiments ([Figure 3A](#fig3){ref-type="fig"}). Loss of *[ASI2](http://www.yeastgenome.org/locus/S000005103/overview)*, but not *[ASI3](http://www.yeastgenome.org/locus/S000004953/overview)*, also affected recovery of ubiquitinated [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ ([Figure 3B](#fig3){ref-type="fig"}), suggesting that [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) is ubiquitinated in an [Asi1](http://www.yeastgenome.org/locus/S000004725/overview)- and [Asi2](http://www.yeastgenome.org/locus/S000005103/overview)-dependent manner.

![Asi1-dependent ubiquitination of Pom33 does not lead to its degradation by the proteasome. (A) Lysates from an untagged control strain, Ubiquitin-Pom33-GFP~1--10~, Pom33-GFP~1--10~, and *asi1*∆ Pom33-GFP~1--10~ were probed with anti-GFP antibodies to determine levels of Pom33 relative to the loading control histone H4. Ubiquitinated proteins were isolated from lysates using an anti-ubiquitin antibody, followed by western blotting using an anti-GFP antibody. The signal in the pull-down was quantitated and adjusted according to input levels, with the level in the untagged and Ub-Pom33-GFP~1--10~ controls set to 0 and 1, respectively. Note, the lysate is 1% of the protein used for the pull-down. (B) Cells containing *asi2*∆ and *asi3*∆ Pom33-GFP~1--10~ were analyzed alongside strains in (A). The lysate is 0.4% of the pull-down. (C) Time course showing that Vtc1-GFP~1--10~ but not Pom33-GFP~1--10~ is stabilized in cells lacking Asi1 after addition of CHX. (D) Quantitation of Vtc1-GFP~1--10~ and Pom33-GFP~1--10~ protein levels from WBs in (E) showed the amount of protein remaining at each time point relative to the histone H4 loading control. (E) Time course to determine total levels of Pom33-13xmyc in wild-type and *cim3-1* cells at 37°. Cells were shifted to the nonpermissive temperature for 45 min before addition of CHX, which inhibits protein synthesis. Western blotting was done to detect Pom33-13xmyc on the top and Clb2 on the bottom. (F) Quantitation of Pom33-13xmyc in (F) and Clb2 protein levels from WBs in (E) showed the amount of protein remaining at each time point relative to the histone H4 loading control. (G) Pom33-GFP~1--10~ with and without Asi1-DUb expressed. (H) Total levels of Pom33-GFP~1--10~ with and without Asi1-DUb expressed. (I) Frequency of Pom33-GFP~1--10~ puncta, DUb off: *n* = 95 cells, DUb on: *n* = 96 cells. Bar, 2 μm. *P*-values were determined by Students *t*-test. Note, cells in (A, B, and E--I) also contain GFP~11~-mCherry-Pus1. CHX, cycloheximide; IP, immunoprecipitation; WB, western blot.](1269f3){#fig3}

Total [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) proteins levels do not change in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ ([Figure 2B](#fig2){ref-type="fig"}) and it does not appear to be polyubiquitinated ([Figure 3, A and B](#fig3){ref-type="fig"}), suggesting that [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) is not actively degraded. To formally test whether [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) stability is affected by loss of *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)*, we performed a cycloheximide chase experiment with cells containing GFP~11~-mCherry-[Pus1](http://www.yeastgenome.org/locus/S000006133/overview) and [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~, or [Vtc1](http://www.yeastgenome.org/locus/S000000874/overview)-GFP~1--10~, a previously characterized INMAD target whose INM levels are regulated by [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) ([@bib30]). Cycloheximide was added to cells to inhibit protein synthesis so that the stability of proteins could be assayed over time by western blot analysis ([Figure 3, C and D](#fig3){ref-type="fig"}). Both [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ and [Vtc1](http://www.yeastgenome.org/locus/S000000874/overview)-GFP~1--10~ levels decreased during the cycloheximide chase but only [Vtc1](http://www.yeastgenome.org/locus/S000000874/overview)-GFP~1--10~ was stabilized by *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆, confirming the idea that [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) stability is [Asi1](http://www.yeastgenome.org/locus/S000004725/overview)-independent. The decrease in [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) levels is not the result of 26S proteasome degradation as we observed a similar decrease in the levels of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-13xmyc in wild-type cells and *[cim3-1](https://www.yeastgenome.org/locus/S000003016)*, a mutant that disrupts the proteasome lid component [Rpt6](http://www.yeastgenome.org/locus/S000003016/overview) ([@bib24]; [@bib48]) ([Figure 3, E and F](#fig3){ref-type="fig"}). [Clb2](http://www.yeastgenome.org/locus/S000006323/overview), a cell cycle protein known to be degraded by the proteasome ([@bib49]; [@bib15]), served as a control that showed stabilization in *[cim3-1](https://www.yeastgenome.org/locus/S000003016)* ([Figure 3, E and F](#fig3){ref-type="fig"}), while histone H4 was a loading control since its levels and stability are unaffected by temperature, cycloheximide, or proteasome inhibition. It is unclear why [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) protein levels decrease over time during the cycloheximide chase, but the fact that we saw similar decreases with different epitopes indicates that it is unlikely to be related to the epitope tag.

If [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) is ubiquitinated but not degraded by the proteasome, what role does [Asi1](http://www.yeastgenome.org/locus/S000004725/overview)-dependent ubiquitination play in the regulation and function of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)? One attractive idea is that [Asi1](http://www.yeastgenome.org/locus/S000004725/overview)-dependent ubiquitination may modulate [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) INM distribution, similar to the way that ubiquitination of proteins is involved in different processes such as nucleocytoplasmic trafficking. Examples of this include p53, in which monoubiquitination is thought to expose a nuclear export signal ([@bib34]; [@bib33]; [@bib41]), and cytidydyltransferase (CCTα), where monoubiquitination blocks its nuclear localization signal ([@bib11]). To test this idea, we employed an inducible version of [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) fused to the deubiquitinating domain of Herpes Virus UL36 ([Asi1](http://www.yeastgenome.org/locus/S000004725/overview)-DUb) ([@bib36], [@bib37]). This [Asi1](http://www.yeastgenome.org/locus/S000004725/overview)-DUb is designed to deubiquitinate [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) targets as [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) acts on them, allowing us to assay the specific role of ubiquitination without lingering concerns of indirect effects caused by chronic removal of *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)*. Although [Asi1](http://www.yeastgenome.org/locus/S000004725/overview)-DUb had little effect on total [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) protein levels, its induction resulted in increased frequency and extent of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ puncta formation at the INM ([Figure 3, G--I](#fig3){ref-type="fig"}), a phenotype very similar to that of *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆. The appearance of the [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) puncta upon induction of the [Asi1](http://www.yeastgenome.org/locus/S000004725/overview)-DUb suggest that their formation is a direct consequence of deubiquitination and supports the idea that [Asi1](http://www.yeastgenome.org/locus/S000004725/overview)-dependent ubiquitination of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) regulates its INM distribution.

If ubiquitination of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) contributes to its normal INM distribution, then constitutive ubiquitination by fusion of ubiquitin to [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) might rescue the puncta phenotype seen in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ mutants. To test this, we first measured the INM intensity, using a split-GFP signal, of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ and Ub-[Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ in wild-type and *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ cells carrying GFP~11~-mCherry-[Pus1](http://www.yeastgenome.org/locus/S000006133/overview), finding that Ub-[Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ partially rescued overall INM intensity in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ ([Figure 4, A and B](#fig4){ref-type="fig"}). Next, we compared the frequency and size of puncta in wild-type and *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ cells, with GFP~11~-mCherry-[Pus1](http://www.yeastgenome.org/locus/S000006133/overview) and [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~, or Ub-[Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~, expressed in single copy at the *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* locus as the sole copy of *[POM33](http://www.yeastgenome.org/locus/S000003946/overview)* in the cell. As expected, the frequency and size of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ puncta increased in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ compared to wild-type ([Figure 4, A--C](#fig4){ref-type="fig"}). However, expression of Ub-[Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ rescued the frequency and size phenotypes in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ cells, with fewer puncta ([Figure 4, A--C](#fig4){ref-type="fig"}) as well as smaller puncta size ([Figure 4C](#fig4){ref-type="fig"}, bottom). Therefore, attaching ubiquitin to [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) bypasses the requirement for [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) for INM distribution, strongly suggesting that [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) directly modifies [Pom33](http://www.yeastgenome.org/locus/S000003946/overview). Because modification of N-terminal residues can affect protein stability through the N-end rule pathway ([@bib62]; [@bib55]), we examined expression levels by western blotting. This analysis showed that [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ and Ub-[Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ were present at similar levels in wild-type cells ([Figure 4D](#fig4){ref-type="fig"}).

![Expression of Ub-Pom33-GFP~1--10~ reduces puncta frequency and size in *asi1*∆. (A) Example images of Pom33-GFP~1--10~, *asi1*∆ Pom33-GFP~1--10~, Ub-Pom33-GFP~1--10~, and *asi1*∆ Ub-Pom33-GFP~1--10~. Cells are also expressing the nuclear reporter GFP~11~-mCherry-Pus1. (B) Quantification of strains in (A); intensities measured as a ratio of reconstituted GFP (488) signal over Pus1 (561) signal. (C) For strains depicted in (A), the frequency of Pom33-GFP~1--10~ puncta was counted (top) and the average puncta width measured by FWHM of fluorescence intensity at the puncta (bottom). Total *n* depicted on graphs. Error bars equal SEM. (D) Quantitation of total Pom33 protein levels for Pom33-GFP~1--10~, *asi1*∆ Pom33-GFP~1--10~, Ub-Pom33-GFP~1--10~, and *asi1*∆ Ub-Pom33-GFP~1--10~ strains by western blot, normalizing to histone H4 signal. Average ratios from four different experiments are shown below. Bar, 2 μm. FWHM, full width at half maximum.](1269f4){#fig4}

Pom33 INM puncta contain NPC components {#s12}
---------------------------------------

Punctate distribution at the NE has been previously reported for the SPB, nuclear--vacuolar junction, intranuclear quality control, and storage for incomplete NPC (SINC) components: [Spc42](http://www.yeastgenome.org/locus/S000001525/overview), [Nvj1](http://www.yeastgenome.org/locus/S000001238/overview), [Cmr1](http://www.yeastgenome.org/locus/S000002315/overview), and [Chm7](http://www.yeastgenome.org/locus/S000003585/overview), respectively ([@bib27]; [@bib64], [@bib65]; [@bib22]; [@bib63]). After replacing GFP~11~-mCherry-[Pus1](http://www.yeastgenome.org/locus/S000006133/overview) with GFP~11~-[Pus1](http://www.yeastgenome.org/locus/S000006133/overview), we examined colocalization of the split-GFP signal in [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ strains using mCherry-tagged proteins marking each of these NE puncta-associated structures. In most cells, [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~/GFP~11~-[Pus1](http://www.yeastgenome.org/locus/S000006133/overview) did not colocalize with any of the tested NE proteins (Figure S5). Moreover, if we deleted key components involved in the formation of nuclear subcomplexes, we did not see an effect on the size or frequency of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) puncta (Figure S5; data not shown). This result was particularly surprising as it suggests that [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) puncta represent a novel nuclear subcompartment that is distinct, particularly from the SINC that has been previously described for incompletely assembled NPCs ([@bib64], [@bib65]).

To better understand the nature of the [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) puncta, we were interested in determining whether soluble nucleoporins not present in our screen were also present in foci. We localized at least one component from each NPC subcomplex in wild-type and *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ cells, including the outer-ring components [Nup120](http://www.yeastgenome.org/locus/S000001540/overview) and [Nup145C](http://www.yeastgenome.org/locus/S000003060/overview), the inner-ring protein [Nup188](http://www.yeastgenome.org/locus/S000004571/overview), the central channel component [Nup57](http://www.yeastgenome.org/locus/S000003351/overview), and the basket proteins [Nup2](http://www.yeastgenome.org/locus/S000004327/overview) and [Mlp2](http://www.yeastgenome.org/locus/S000001411/overview) ([Figure 5A](#fig5){ref-type="fig"}) ([@bib3]; [@bib2]). [Nup145C](http://www.yeastgenome.org/locus/S000003060/overview), [Nup57](http://www.yeastgenome.org/locus/S000003351/overview), [Nup2](http://www.yeastgenome.org/locus/S000004327/overview), and [Mlp2](http://www.yeastgenome.org/locus/S000001411/overview) were unaffected by removal of *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)*; however, [Nup120](http://www.yeastgenome.org/locus/S000001540/overview) and [Nup188](http://www.yeastgenome.org/locus/S000004571/overview) exhibited punctate foci specifically in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ mutants ([Figure 5B](#fig5){ref-type="fig"}). Over half of the [Nup120](http://www.yeastgenome.org/locus/S000001540/overview)-mCherry or [Nup188](http://www.yeastgenome.org/locus/S000004571/overview)-mCherry puncta seen in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ colocalize with [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~/GFP~11~-[Pus1](http://www.yeastgenome.org/locus/S000006133/overview) ([Figure 5C](#fig5){ref-type="fig"}). It is tempting to speculate that these puncta contain full or complete NPCs; however, it is important to note that we only observe puncta formation with a few nucleoporins. While we detected [Pom33](http://www.yeastgenome.org/locus/S000003946/overview)-GFP~1--10~ in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ by immuno-electron microscopy (EM) at NPCs (data not shown), consistent with previous immuno-EM data in wild-type cells ([@bib10]), NPCs do not cluster in cells lacking *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)* (data not shown). Further, [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) did not localize to any recognizable NE landmark other than NPCs (data not shown), pointing to the possibility that [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) distributes to a novel subnuclear component in the absence of [Asi1](http://www.yeastgenome.org/locus/S000004725/overview).

![Nup188 and Nup120 colocalization with Pom33 puncta in *asi1*∆. (A) Cartoon of the NPC. Nucleoporins tested included the outer ring components Nup120 and Nup145C, the inner ring Nup188, the central channel nucleoporin Nup57, and the basket-associated Mlp2 and Nup2. (B) Localization of nucleoporins in (A) was assayed in wild-type and *asi1*∆ cells. Nup120 and Nup188 displayed more puncta in *asi1*∆, as indicated by blue arrows. (C) Example images of Pom33-GFP~1--10~/GFP~11~-Pus1 with either Nup120-mCherry or Nup188-mCherry, in wild-type and *asi1*∆. Bar, 2 μm. NPC, nuclear pore complex.](1269f5){#fig5}

Discussion {#s13}
==========

Mechanisms that control INM protein dynamics are poorly understood. Using split-GFP, we performed a systematic screen of over 700 membrane proteins, comparing INM levels between wild-type cells and mutants in the E3 ubiquitin ligases [Asi1](http://www.yeastgenome.org/locus/S000004725/overview), [Doa10](http://www.yeastgenome.org/locus/S000001292/overview), and [Hrd1](http://www.yeastgenome.org/locus/S000005373/overview), the E2 ubiquitin-conjugating enzyme [Ubc7](http://www.yeastgenome.org/locus/S000004624/overview), and the vacuolar peptidase [Pep4](http://www.yeastgenome.org/locus/S000006075/overview). Our data overlap to a limited degree with previous studies examining substrates of these enzymes ([@bib19]; [@bib30]). However, our ability to specifically and unequivocally assay changes at the INM enabled us to extend our understanding of INM quality control in several important ways. Previous work hypothesized that the primary role of INMAD is to remove foreign substrates from the INM, *i.e.*, proteins that have diffused in via NPCs but failed to diffuse back out, due to associated protein tags or lesions within the polypeptide ([@bib19]; [@bib30]). However, we found that deletion of *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)* preferentially affected INM components compared to other mutants examined. In both our screen and our follow-up studies, we show that loss of *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)* results in increased levels of *bona fide* INM proteins, such as [Pom33](http://www.yeastgenome.org/locus/S000003946/overview), [Per33](http://www.yeastgenome.org/locus/S000004054/overview), [Asi2](http://www.yeastgenome.org/locus/S000005103/overview), and [Heh2](http://www.yeastgenome.org/locus/S000002866/overview). This suggests that [Asi1](http://www.yeastgenome.org/locus/S000004725/overview), and by extension INMAD, plays a role in proteostasis of wild-type INM proteins, not just proteins mistargeted to the INM.

[Asi1](http://www.yeastgenome.org/locus/S000004725/overview) and [Asi3](http://www.yeastgenome.org/locus/S000004953/overview) are thought to form a heterodimeric E3 ligase, which binds to the accessory factor [Asi2](http://www.yeastgenome.org/locus/S000005103/overview) to ubiquitinate substrates in the nucleus and at the INM ([@bib68]; [@bib19]; [@bib30]). Although subtle differences between deletion mutants have been reported ([@bib19]; [@bib30]; [@bib43]), the prevailing model in the field supports the idea of an Asi complex ([@bib6]). Several lines of evidence presented here suggest that [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) is a direct [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) substrate and, by extension, a substrate of the Asi complex. First, [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) is ubiquitinated in an [Asi1](http://www.yeastgenome.org/locus/S000004725/overview)-dependent manner. Second, expression of [Asi1](http://www.yeastgenome.org/locus/S000004725/overview)-DUb recapitulated the [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) puncta phenotype seen in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆ mutants. Lastly, a constitutively ubiquitinated [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) (Ub-[Pom33](http://www.yeastgenome.org/locus/S000003946/overview)) largely reversed puncta formation in *[asi1](http://www.yeastgenome.org/locus/S000004725/overview)*∆. Taken together, these data suggest that [Asi1](http://www.yeastgenome.org/locus/S000004725/overview), or the Asi complex, normally acts to ubiquitinate a pool of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview), which results in its uniform NE distribution. Given that the Asi complex is nonessential except when cells are placed under stress, this uniform distribution of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) is likely not required for NPC function and immunoprecipitation experiments suggest that only a small fraction of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) is ubiquitinated.

[Asi1](http://www.yeastgenome.org/locus/S000004725/overview)-dependent [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) ubiquitination does not appear to be a signal for degradation. A ladder of polyubiquitinated [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) was not observed. In addition, [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) levels did not change when it was fused to ubiquitin or expressed in a proteasome mutant. Our data suggest that ubiquitination regulates [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) localization in much the same way that monoubiquitination is used throughout the endomembrane system to control subcellular localization or endocytosis ([@bib26]; [@bib14]). Analysis of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) localization determinants in budding yeast suggests that the C-terminal 65 amino acids are important for both stability and NPC localization ([@bib18]), making it tempting to speculate that residues in this region are ubiquitinated. Attempts to map a ubiquitinated lysine residue were unsuccessful, suggesting that multiple lysines are sufficient (data not shown). Examination of our [Asi1](http://www.yeastgenome.org/locus/S000004725/overview) substrates, along with previously described targets, did not show a particular motif targeting them to the ligase. However, it has been previously proposed that amphipathic helices play a role in [Asi2](http://www.yeastgenome.org/locus/S000005103/overview) degradation and [Doa10](http://www.yeastgenome.org/locus/S000001292/overview) substrate recognition ([@bib45]; [@bib8]). Given that [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) has at least two amphipathic helices in its C-terminus that play a role in NPC targeting and membrane binding, one hypothesis is that these domains are also important for [Asi1](http://www.yeastgenome.org/locus/S000004725/overview)-dependent ubiquitination. More generally, INMAD-dependent control of these common motifs could play a role in the regulation of NPC assembly and NE compartmentalization.

What is the role of INMAD regulation of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) and other resident INM proteins? No obvious changes to nuclear structure, including NPC distribution, have been reported for cells lacking *[ASI1](http://www.yeastgenome.org/locus/S000004725/overview)* by EM and the ligase is not essential under normal growth conditions ([@bib19]). Colocalization with [Nup120](http://www.yeastgenome.org/locus/S000001540/overview) and [Nup188](http://www.yeastgenome.org/locus/S000004571/overview) suggests that the [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) puncta contain at least some additional NPC components, even though no recognizable NPCs were seen cytologically (data not shown). We do not believe that these are improperly assembled NPCs, as puncta did not colocalize with the SINC. Instead, our data suggest that [Pom33](http://www.yeastgenome.org/locus/S000003946/overview) aggregates in a novel INM structure. Since the INMAD has only been investigated for its role in the degradation of targets, it will be of future interest to determine whether the INMAD components mediate ubiquitination of other proteins to alter their localization or if TMEM33, the metazoan ortholog of [Pom33](http://www.yeastgenome.org/locus/S000003946/overview), is also ubiquitinated. These types of studies will elucidate the role of INMAD in normal nuclear function.
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